abstract |
A pharmaceutical composition comprising a macrolide compound for oral administration, wherein the dissolution of the macrolide compound is by a process known as sustained release; and a sustained release pharmaceutical composition comprising a solid solution mixture wherein the macrolide compound is present in an amorphous state in a solid base. |